Dr. Ducore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 Stockton Blvd
TICON I Bldg
Sacramento, CA 95817Phone+1 916-734-3461Fax+1 916-734-3591
Education & Training
- University of ColoradoResidency, Pediatrics, 1975 - 1977
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1974 - 1975
- University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1973 - 1974
- Duke University School of MedicineClass of 1973
Certifications & Licensure
- CA State Medical License 1988 - 2025
- TX State Medical License 1980 - 2018
- MD State Medical License 1978 - 1990
- CO State Medical License 1975 - 1989
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Publications & Presentations
PubMed
- 453 citationsHemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.Lindsey A. George, Spencer K. Sullivan, Adam Giermasz, John E.J. Rasko, Benjamin J. Samelson-Jones
The New England Journal of Medicine. 2017-12-06 - 228 citationsThe North American Immune Tolerance Registry: practices, outcomes, outcome predictors.Donna DiMichele, B. L. Kroner, S. Adair, J. Addiego, V. Anderson
Thrombosis and Haemostasis. 2002-02-05 - 59 citationsTobacco Smoke Exposure and the Risk of Childhood Acute Lymphoblastic and Myeloid Leukemias by Cytogenetic SubtypeCatherine Metayer, Luoping Zhang, Joseph L. Wiemels, Karen Bartley, Joshua D. Schiffman
Cancer Epidemiology, Biomarkers & Prevention. 2013-07-12
Press Mentions
- UC Davis Health Discovers Increased Risk of Leukemia in Children with down SyndromeMay 7th, 2021
- Miracle of Hemophilia Drugs Comes at A Steep PriceMarch 5th, 2018
- Octapharma Announces Two Hemophilia A Clinical Trials to Utilize WILATENovember 14th, 2016
Grant Support
- RNA Changes By L-PAM In Human CellsNational Cancer Institute1988–1989
- RNA Changes By L-PAM In Human CellsNational Cancer Institute1986–1988
- Mechanism Of Action Of Bifunctional Alkylating AgentsNational Cancer Institute1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: